115 related articles for article (PubMed ID: 37856936)
1. Assessment of breast cytoarchitecture and its associated axillary lymph node status under normal and pathological conditions in Egyptian women.
Mansour O; Kazem A; El Wakil A
Tissue Cell; 2023 Dec; 85():102244. PubMed ID: 37856936
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Relevance and Prognostic Value of Androgen Receptor in Mammary Paget's Disease with Underlying Invasive Ductal Carcinoma.
Zhang M; Meng X; Guo C; Liu J; Xing Z; Wang X; Wang X
Oncol Res Treat; 2020; 43(7-8):346-353. PubMed ID: 32645702
[TBL] [Abstract][Full Text] [Related]
3. The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma.
Wong SM; Freedman RA; Sagara Y; Stamell EF; Desantis SD; Barry WT; Golshan M
Cancer; 2015 Dec; 121(24):4333-40. PubMed ID: 26376021
[TBL] [Abstract][Full Text] [Related]
4. Axillary lymph node status and invasive lobular breast cancer : Analysis of the Clinical Tumor Register of the AGO Austria.
Danzinger S; Pöckl K; Kronawetter G; Pfeifer C; Behrendt S; Gscheidlinger P; Harrasser L; Mühlböck H; Dirschlmayer W; Schauer C; Reitsamer R; Uher H; Schönau K; Delmarko I; Singer CF
Wien Klin Wochenschr; 2023 Sep; 135(17-18):463-471. PubMed ID: 37010596
[TBL] [Abstract][Full Text] [Related]
5. Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a multi-institutional retrospective analysis.
Gao W; Zeng Y; Fei X; Chen X; Shen K
Breast Cancer Res Treat; 2020 Nov; 184(1):193-202. PubMed ID: 32740809
[TBL] [Abstract][Full Text] [Related]
6. Invasive lobular carcinoma: clinicopathological features and subtypes.
Danzinger S; Hielscher N; Izsó M; Metzler J; Trinkl C; Pfeifer C; Tendl-Schulz K; Singer CF
J Int Med Res; 2021 Jun; 49(6):3000605211017039. PubMed ID: 34187216
[TBL] [Abstract][Full Text] [Related]
7. Invasive cribriform carcinoma in a Chinese population: comparison with low-grade invasive ductal carcinoma-not otherwise specified.
Zhang W; Zhang T; Lin Z; Zhang X; Liu F; Wang Y; Liu H; Yang Y; Niu Y
Int J Clin Exp Pathol; 2013; 6(3):445-57. PubMed ID: 23412348
[TBL] [Abstract][Full Text] [Related]
8. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
9. Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study.
Zhang Y; Mo M; Li JW; Zhou Y; Wu J; Yu KD; Shen ZZ; Shao ZM; Liu GY
Eur J Surg Oncol; 2016 Aug; 42(8):1146-52. PubMed ID: 27365197
[TBL] [Abstract][Full Text] [Related]
10. Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery.
Guillot E; Vaysse C; Goetgeluck J; Falcou MC; Couturaud B; Fitoussi A; Fourchotte V; Laki F; Malhaire C; Sigal-Zafrani B; Sastre-Garau X; Bollet MA; Mosseri V; Reyal F
Breast; 2014 Apr; 23(2):97-103. PubMed ID: 24388733
[TBL] [Abstract][Full Text] [Related]
11. 14-3-3ζ promoted invasion and lymph node metastasis of breast invasive ductal carcinoma with HER2 overexpression.
Wan D; Zhang Y; Yu Q; Li F; Zhuo J
Pathol Res Pract; 2021 Nov; 227():153619. PubMed ID: 34560418
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implication of the tumor location according to molecular subtypes in axillary lymph node-positive invasive ductal cancer in a Korean population.
Lim ST; Choi JE; Kim SJ; Kim HA; Kim JY; Park HK; Suh YJ
Breast Cancer Res Treat; 2016 Apr; 156(3):473-483. PubMed ID: 27041335
[TBL] [Abstract][Full Text] [Related]
13. Predictive Value of
Song BI; Kim HW; Won KS
Ann Surg Oncol; 2017 Aug; 24(8):2174-2181. PubMed ID: 28432480
[TBL] [Abstract][Full Text] [Related]
14. Mucinous Breast Carcinoma: Clinicopathological Comparison With Invasive Ductal Carcinoma.
Hashmi AA; Zia S; Yaqeen SR; Ahmed O; Asghar IA; Islam S; Afzal A; Irfan M; Zia F; Ali J
Cureus; 2021 Mar; 13(3):e13650. PubMed ID: 33824803
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of fine needle aspirates processed by ThinPrep® for the assessment of axillary lymph node status in patients with invasive carcinoma of the breast.
Jing X; Wey E; Michael CW
Cytopathology; 2013 Dec; 24(6):372-6. PubMed ID: 23020285
[TBL] [Abstract][Full Text] [Related]
16. False negative results in axillary lymph nodes by ultrasonography and ultrasonography-guided fine-needle aspiration in patients with invasive ductal carcinoma.
Park SH; Kim EK; Park BW; Kim SI; Moon HJ; Kim MJ
Ultraschall Med; 2013 Dec; 34(6):559-67. PubMed ID: 23258771
[TBL] [Abstract][Full Text] [Related]
17. Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast.
Fernández B; Paish EC; Green AR; Lee AH; Macmillan RD; Ellis IO; Rakha EA
J Clin Pathol; 2011 Nov; 64(11):995-1000. PubMed ID: 21712309
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
[TBL] [Abstract][Full Text] [Related]
19. Mammographic features are associated with clinicopathological characteristics in invasive breast cancer.
Jiang L; Ma T; Moran MS; Kong X; Li X; Haffty BG; Yang Q
Anticancer Res; 2011 Jun; 31(6):2327-34. PubMed ID: 21737659
[TBL] [Abstract][Full Text] [Related]
20. Axillary Lymph Node-to-Primary Tumor Standard Uptake Value Ratio on Preoperative (18)F-FDG PET/CT: A Prognostic Factor for Invasive Ductal Breast Cancer.
Kim YH; Yoon HJ; Kim Y; Kim BS
J Breast Cancer; 2015 Jun; 18(2):173-80. PubMed ID: 26155294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
